The Centers for Disease Control and Prevention's (CDC) advisory committee has voted to recommend Pfizer-BioNTech's COVID-19 vaccine be administered to children ages 12 to 15.
On Wednesday, 14 members of the Advisory Committee on Immunization Practices (ACIP) voted 'yes' and one member recused herself.
It comes two days after the U.S. Food and Drug Administration (FDA) approved the shot for emergency use in younger teens.
The vaccine was authorized for Americans aged 16 and older in December 2020 and Pfizer has been in trials for teens since October of last year.
With the formal recommendation from ACIP, most states will likely begin giving out the shot to younger teenagers on Thursday
Expanding vaccine availability to younger teenagers will make about 17 million additional Americans eligible for vaccination, a step that some see as critical to reaching herd immunity and improving safety as children return to school.
However, some parents and experts have questioned whether vaccinating children is really for their own benefit, or if it is risking the effects of a new vaccine in kids in order to protect adults, when only 0.1 percent of U.S. Covid fatalities have been in people under 18.
CDC's advisory committee recommended that Pfizer-BioNTech's COVID-19 vaccine be administered to children ages 12 to 15
This is a breaking news story and will be updated.